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1. Introduction  
Numerous epidemiological studies have demonstrated a consistent link between 
particulate air pollution, especially fine particulate matter with aerodynamic 
diameter<2.5μm (PM2.5), and increased cardiopulmonary morbidity and mortality (1-5). 
The mechanisms responsible for such an association have been the focus of recent 
environmental health studies. The most promising and frequently studied mechanism is 
PM related effects on cardiac autonomic modulation (6-10). In a study specifically 
designed to investigate the time course of PM on cardiac autonomic modulation, Cavallari 
et al. reported an early and a later phase response, with the early effects at 2 hours and 
delayed effects at 9-13 hours after exposure (11). Since cardiac autonomic modulation 
regulates important cardiac electrophysiological activities, other electrophysiological 
parameters have been proposed as important markers of electric activity disturbances 
associated with PM.  These markers include ventricular repolarization, ischemic potential, 
arrhythmia, and other waveform changes. For instance, it was reported (12-14) that air 
pollution is associated with severe arrhythmia in patients with implantable cardioverter 
defibrillators (ICDs). Recently, it was reported that elevated GIS-estimated ambient PM2.5 
exposures one day prior to the ECG measurement were associated with increased odds of 
PVC in women enrolled in the Women’s Health Initiative (WHI) clinical trials study (15). 
However, very little is known about PM effects on various cardiac electrophysiological 
parameters from a study specifically designed to examine the individual-level exposures 
to PM2.5 and all ECG-based parameters.  
We therefore designed the Air Pollution and Cardiac Risk and its Time Course (APACR) 
study to investigate the effects and time course of individual-level exposures to PM2.5 on 
various cardiac electrophysiological parameters. The individual findings on each of the 
electrophysiological premasters have been reported elsewhere (7;16-19). This chapter 
summarizes those major findings and presents the overall findings indicating various time-
courses from those publications.  
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2. Materials and methods 
2.1 Population 
The APACR study successfully examined 106 individuals, with a response rate of 
approximately 75%. The study was designed as a 24-hour continuous real-time monitoring 
of PM2.5 exposures and cardiac electrophysiological parameters, with the blood samples 
drawn from the beginning and end of 24 hours to obtain measures of the blood markers 
(7;16). Briefly, all study participants were recruited from communities in central 
Pennsylvania, primarily from the Harrisburg metropolitan area. The inclusion criteria for 
the study included nonsmoking adults  45 years old who had not been diagnosed with 
severe cardiac problems (defined as diagnosed valvular heart disease, congenital heart 
disease, acute myocardial infarction or stroke within 6 months, or congestive heart failure). 
Approximately 75% of the individuals who were contacted and who met our inclusion 
criteria were enrolled in the APACR study. Our targeted sample size was 100 individuals, 
and we enrolled and examined 106 individuals for the APACR study. Individual-level PM2.5 
and Holter ECG monitoring were initiated between 0800 and 1000 hours on the first day, 
immediately after participants were administered a standardized questionnaire, underwent 
a brief physical examination, and a fasting blood draw by a trained and certified research 
nurse. The next morning, the participants returned to remove the monitors and had their 
second blood draw. The APACR study has maintained approval by the Penn State 
University College of Medicine institutional review board. All participants gave written 
informed consent prior to their participation in the study.  
2.2 Personal PM2.5 exposures 
The APACR study used a personal PM2.5 DataRam (pDR, model 1200, Thermo Scientific, 
Boston, MA) for real-time 24-hour personal PM2.5 exposure assessment. Details of the 
exposure assessment (7;16) and of the instrument’s performance have been reported 
elsewhere (20-23). Real-time PM2.5 concentrations were recorded at 1-minute intervals and 
averaged over 30-minute segments, beginning on the hour or half hour. Therefore, we 
calculated, on a 30-minute basis, the corresponding time-of-the-day specific average 
exposure to PM2.5 for each participant as a time-dependent repeated measures over a 24-
hour period. Thus, each participant contributed 48 exposure data points.  
2.3 Electrophysiological variables 
We used the high sampling rate (1000 Hz) 12-lead HScribe Holter System (Mortara 
Instrument, Inc.) for 24-hour Holter beat-to-beat ECG data collection. This high sampling rate 
Holter system is available for research use only. The high sampling rate significantly increases 
the resolution and enhances the accurate capture of fiducial point and various wave form 
measures. The ECG data were scanned to a designated computer for offline processing, using 
specialized software by an experienced investigator. One experienced investigator followed 
established protocols to identify machine scanned errors, to verify the Holter identified, and to 
identify and label additional electronic artifacts and arrhythmic beats in the ECG recording. 
The reader adjudicated files are saved and used for the calculation of the following five ECG 
variable categories: the heart rate variability (HRV), ectopy, ventricular repolarization, 
potential ischemia, and P-wave related measures.  All variables were calculated on a 30-
minute basis. Thus, they were treated as time-of-the-day specific repeated measures over a 24-
hour period. Each participant contributed 48 dependent variable data points. 
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2.4 HRV variables 
We used the above mentioned “reader adjudicated” beat-to-beat ECG for HRV analysis. 
From the “reader adjudicated” data, we eliminated artifacts and other arrhythmic beats, and 
only retained normal R to R intervals. We then performed time and frequency domain HRV 
analysis [Fast Fourier Transformation (FFT)] using the HRV Analysis System (Department 
of Physics, University of Kuopio, Finland). All calculations were based on current 
recommendations (24). Briefly, the adjacent RR interval data were interpolated using a 
piecewise cubic spline approach, with a 2 Hz sampling rate. The FFT was performed on the 
equidistantly interpolated RR time series. We used a second order polynomial model to 
remove the slow non-stationary trends of the HRV signal. The following HRV indices were 
calculated as measures of CAM: standard deviation of all RR intervals (SDNN, ms), square 
root of the mean of the sum of the squares of differences between adjacent RR intervals 
(RMSSD, ms), power in the high frequency range (0.15-0.40 Hz, HF), power in the low 
frequency range (0.04-0.15 Hz, LF), and the LF/HF ratio. 
2.5 Arrhythmia frequency 
We calculated the frequency of ventricular and supraventricular ectopy. No participant had 
other less frequent arrhythmic beats, such as atrial fibrillation/flutter and supraventricular 
and ventricular tachycardia in our study period. 
2.6 Ventricular repolarization 
We calculated QT Prolongation Index (QTI, %) as a primary measure of ventricular 
repolarization. The duration of ventricular repolarization is often estimated by Bazett’s heart 
rate-corrected QT interval (QTc) (25). Although QTc and QTI (26) are strongly correlated (r = 
0.96), QTI is less rate-sensitive (26;27) and has a higher repeatability than QTc (28;29). We 
focused on QTI, but also reported other HR-corrected QT indices are also available for 
analysis. 
2.7 P wave related measures  
The following P-wave based atrial fibrillation/flutter (AF) predictors were calculated from 
the normal heart beats: 
- P wave duration (ms), as the time between the first “onset” and last “offset” deflection 
from the isoelectro line. 
- PR duration (ms), as the time between the first onset defection of the P and R wave, (the 
latter representing the onset of ventricular depolarization), with longer PR duration the 
higher risk of AF. 
- P wave complexity (unitless), as the average ratio of the second to the first eigenvalue, 
the value of which reflects the relative complexity of atrial depolarization (30), with 
more complexity in the atrial depolarization indicating the higher risk of AF. 
2.8 ST-height 
The calculated ST-height included beat-to-beat ST-height from 10 leads (inferior leads II, III, 
and aVF; lateral leads I, V5, and V6; septal leads V1 and V2; and anterior leads V3 and V4), 
defined as the distance between the J point, and 60 ms after the J point. We then calculated 
on a 30-minute basis the average ST-height for each lead. Therefore, the ST-height measures 
are treated as repeated outcome measures, and each individual contributed 48 data points 
for each of the 10 leads.  
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2.9 Other individual-level covariables 
A standardized questionnaire was used to collect the following individual-level 
information: (a) demographic variables, including age, race, sex, and highest education 
level; (b) medication uses, including anti-anginal medication, anti-hypertensive medication, 
and anti-diabetic medication; and (c) physician diagnosed chronic disease history, including 
CVD (including revascularization procedures and myocardial infarction), hypertension, and 
diabetes. The averages of the 2nd and 3rd measures of seated systolic and diastolic blood 
pressures on Day-1 were used to represent a participant’s blood pressure levels. Day-1 
fasting glucose was measured by the GCRC central laboratory. CVD was defined by anti-
anginal medication use or a history of CVD. Hypertension was defined by anti-hypertensive 
medication use, physician diagnosed hypertension, systolic blood pressure ≥ 140 mmHg, or 
diastolic blood pressure ≥90mm Hg. Diabetes was defined by anti-diabetic medication use, 
physician diagnosed diabetes, or fasting glucose >126 mg/dl. Body mass index (BMI) was 
defined as the ratio of weight to height squared (BMI, kg/m2). 
2.10 Weather variables 
We obtained real-time temperature and relative humidity using the HOBO H8 logger (Onset 
Computer Corporation, Bourne, MA), directly fixed on top of the container housing the 
PM2.5 monitor. The real-time temperature and relative humidity were recorded at 1-minute 
intervals and averaged over 30-minute segments corresponding to the time segments during 
which PM2.5 and ECG variables were measured. The weather variables were treated as 
repeated measures, and each individual contributed 48 data points for each.  
3. Statistical analysis 
In the APACR study, the individual-level, real-time PM2.5 exposure and cardiac 
electrophysiology outcomes were measured over a 24 hour period.  The PM2.5 and outcome 
summaries were constructed every 30 minutes for all participants, producing 48 repeated 
measures. We extended the distributed lag model (31-33) for statistical analyses. Specifically, 
we constructed polynomial distributed lag models, which enable us to provide 
interpretation of the cumulative effects of the lags included in the model, as well as 
individual lag effects. In a lag distributed model, all lags to be analyzed are entered into a 
single model. The coefficients from the lags are the respective effects from the individual 
lags. The cumulative effect of all lags is the weighted average of individual effects. In 
contrast, the moving average model takes the average of intended lag exposures and relates 
the average with the outcome measured a given total lag units ago. Since PM2.5 exposures 
and ECG outcome data were assessed in parallel over 48 lags (24 hours), we decided a priori 
to model no more than 10 lags, which allowed us to fit the distributed lag models using at 
least 80% of the data. For continuous outcomes (e.g., heart rate-corrected QT intervals) we 
used a linear mixed-effects models framework (34). For count (e.g., PVC count, total ectopy 
count) data we used negative binomial regression model (35) and generalized estimating 
equations (GEE) framework (36). Details of these models have been published (7;16-19).  We 
systematically started from the largest number of lags (lag 0–10), and reduced the total 
number of individual lags by back-eliminating the longer lags (e.g., lag 10), one lag at a time 
until a significant cumulative effect from all the included lags (p < 0.05) was identified. We 
then used this model as our final model for a specific ECG outcome. All results are 
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expressed per 10 μg/m3 increase in PM2.5. We used SAS version 9 (SAS Institute, Inc., Cary, 
NC) for all analyses. Figure 1 graphically represents the individual lag and cumulative 
effects from a distributed lag model.  
 
 
Figure 1.  Panel A.  Analytic Methods – Lag 0 Effect
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Figure 1.  Panel B.  Analytic Methods – Lag 1 Effect
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Figure 1.  Panel C.  Analytic Methods – Lag 0-1 Cumulative Effect
 
 
 
 
Fig. 1. Illustrations of PM2.5 effects from a distributed lag model 
4. Results 
Table 1 presents demographic and clinical characteristics in this community-based sample 
of 106 middle-aged healthy non-smokers. The mean age of the participants was 56 years, 
with 73% non-Hispanic white, 60% females, and 43% classified as having chronic disease 
(CVD, hypertension, or diabetes). The prevalence of CVD, hypertension, and diabetes was 
7.6%, 35.2%, and 7.6%, respectively.  
The average individual-level exposure to PM2.5 (over all 30 minute segments) was 13.49 
(SD=22) µg/m3. The medians of the within-individual interquartile ranges (IQR) for the 
entire study sample on lag 0, lag 0-1, lag 0-2, lag 0-3, and lag 0-4 PM2.5 concentration were 
6.38 µg/m3, 6.57 µg/m3, 5.97 µg/m3, 5.83 µg/m3, and 6.06 µg/m3, respectively, which 
indicates no substantial variation in the IQRs across the window of exposure, supporting 
our decision of reporting the relationship between PM2.5 and ECG parameters per 10 µg/m3 
increase of PM2.5 across all models.  
According to the model selection strategy described above, the final models for each of the 
continuous ECG outcomes are summarized in Table 2, and the results from arrhythmia 
counts as outcome are presented in Table 3. All these models were adjusted for age, sex, 
race, temperature, relative humidity, diabetes, hypertension, and CVD.  From the 
cumulative effects of PM2.5 summarized in Tables 2 and 3, the time course patterns are 
clearly shown as ranging from 30 minutes to several hours of elevated PM2.5 levels. 
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Characteristic All subjects 
Hypertension, Diabetes, or CVD 
No Yes P valuec 
 N=106 N=60 N=45  
Age  56 (7.6) 56 (8.2) 57 (6.8) 0.32 
Gender (% Male) 40 40 40 1.00 
Race  (% non-Hispanic White) 73 72 76 0.66 
Glucose (mg/dL) 89 (25) 85 (10) 94 (36) 0.10 
BMI (kg/m2) 28 (5.9) 26 (4.3) 30 (7.1) <0.01 
CVD (%) 7.6 0.00 18 <0.01 
Hypertension (%) 35 0.00 85 <0.01 
Diabetes (%) 7.6 0.00 18 <0.01 
Systolic Blood Pressure (mm Hg) 122 (16) 117 (12) 128 (18) <0.01 
Diastolic Blood Pressure (mm Hg) 75 (9.2) 73 (8.3) 77 (9.8) 0.02 
College or Higher (%) 79 73 87 0.10 
Hypertensive Medicine Use (%) 19 0.00 44 <0.01 
Diabetic Medicine Use (%) 6.7 0.00 16 <0.01 
Arrhythmia Medicine Use (%) 1.9 0.00 4.4 0.18 
a Results are presented as mean (standard deviation) for continuous variables and percentage for 
categorical variables 
b he median of the within-individual interquartile ranges of PM2.5 concentration. 
c p-value for comparing CVD  and No CVD groups. 
Table 1. Demographic and clinical characteristics of the study populationa 
 
ECG Parameter Lags ß (SE, p value) 
HRV    Log_HF (ms2) Lag 0 -0.003 (0.007) 
 Lag 1 -0.006 (0.005) 
 Lag 2 -0.007 (0.003) * 
 Lag 3 -0.009 (0.004) ** 
 Lag 4 -0.009 (0.004) * 
 Lag 5  -0.009 (0.004) * 
 Lag 6 -0.008 (0.004) * 
 Lag 7 -0.007 (0.003) * 
 Lag 8 -0.005 (0.004) 
 Lag 9 -0.002 (0.005) 
 Lag 10  0.002 (0.008) 
 Cumulative  -0.062 (0.022) ** 
            SDNN (ms) Lag 0 -0.07   (0.21) 
 Lag 1 -0.09   (0.13) 
 Lag 2 -0.12   (0.10) 
 Lag 3 -0.13   (0.10) 
 Lag 4 -0.15   (0.12) 
 Lag 5  -0.16   (0.12) 
 Lag 6 -0.17   (0.11) 
 Lag 7 -0.18   (0.10) 
 Lag 8 -0.18   (0.10) 
 Lag 9 -0.18   (0.15) 
 Lag 10 -0.17   (0.24) 
 Cumulative  -1.59   (0.54) ** 
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ECG Parameter Lags ß (SE, p value) 
QTI (%) Lag 0 0.07 (0.04) * 
 Lag 1 0.04 (0.02) * 
 Lag 2 0.02 (0.02) 
 Lag 3 0.01 (0.03) 
 Lag 4 0.01 (0.03) 
 Lag 5 0.02 (0.02) 
 Lag 6 0.05 (0.03) * 
 Lag 7 0.08 (0.04) * 
 Cumulative  0.32 (0.13) ** 
ST-height   ST-II Lag 0 0.04 (0.08) 
 Lag 1 0.14 (0.06) ** 
 Lag 2 0.20 (0.07) ** 
 Lag 3 0.21 (0.09) ** 
 Lag 4 0.20 (0.16)  
 Cumulative 0.79 ( 0.23) ** 
                    ST-III Lag 0 0.02 (0.07) 
 Lag 1 0.08 (0.05) 
 Lag 2 0.13 (0.06) * 
 Lag 3 0.15 (0.08) * 
 Lag 4 0.14 (0.14) 
 Cumulative 0.52 (0.27)* 
P complexity Lag 0 0.0002 (0.0002) 
 Lag 1 0.0004 (0.0002) ** 
 Lag 2 0.0005 (0.0002) ** 
 Lag 3 0.0004 (0.0004) 
 Cumulative  0.0016 (0.0006) ** 
 
* :  p<0.05     **: p<0.01 
Table 2. Regression coefficient of continuous ECG variables associated with a 10µg/m3 
increment of PM2.5. 
 
Ectopy Variable Lags Rate Ratiob (95%CI) 
PVC (count) Lag 0 (same time) 1.08 (1.05, 1.10) ** 
 Lag 0-1 (30 min. prior)  1.03 (1.00, 1.05) * 
PAC (count) Lag 0 (same time) 0.94 (0.85, 1.04) 
 Lag 0-1 (30 min. prior) 0.97 (0.89, 1.05) 
a The rate ratios were calculating by exponentiating the regression coefficients from distributed lag 
negative binomial models. A rate ratio of 1.05 indicates a 5% increase in ectopy count/30 minutes in 
association with a 10 µg/m3 increase in PM2.5 concentration 
b Adjusted for age, sex, race, chronic disease status, and the same lag period temperature and relative 
humidity. 
*: P value<0.05     **: P value<0.01 
Table 3. The cumulative rate ratiosa (95% CI) of ectopy counts associated with a 10 µg/m3 
increment of PM2.5. 
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To elucidate whether PM2.5 affects inflammatory response as a potential mechanism that 
explains the associations between PM2.5 and ECG-based parameters, we examined the 
association between individual level 24-hour PM2.5 concentration and blood inflammatory 
markers in the APACR study population.  In these analyses, we treated PM2.5 exposure as 
24-hour average from the pDR measures.  Two blood samples were collected from each 
participant, one immediately before and one immediately after the 24-hour study period. 
Concentrations of several inflammation markers were assessed and averaged. Linear 
regression models were used to assess the association between mean 24-hour PM2.5 
exposure and the mean inflammation markers.  Age, race, gender, relative humidity, 
temperature, and participant’s chronic disease status were adjusted for in the regression 
models.  We did not observe significant associations between 24-hour mean PM2.5 
exposure and mean inflammation markers. The regression coefficients (SE) per 10 μg/m3 
increase in PM2.5 were:  -0.02 (0.02) g/dL for albumin, 81 (217) ng/mL for C-reactive 
protein (CRP), -0.56 (0.13) pg/mL for interleukin-1 ǂ (IL-1 ǂ), -0.28 (0.30) pg/mL for 
interleukin-1 ǃ (IL-1 ǃ), -19 (56) pg/mL for macrophage migration inhibitory factor (MIF),  
-1.66 (5.37) pg/mL for tumor necrosis factor-ǂ (TNFǂ), 100 (73) pg/mL for tumor necrosis 
factor soluble receptor I (TNFsRI),and 0.02 (0.09) x 103/mm3 for white blood cell count, 
respectively (all p-values > 0.05). 
Similarly, we also examined the association between individual level 24-hour PM2.5 
concentration and blood hemostatic factors--blood markers of coagulation and thrombosis 
potential in the APACR .  We did not observe significant associations between 24-hour mean 
PM2.5 exposure and mean hemostatic factor levels. The regression coefficients (SE) per 10 
μg/m3 increase in PM2.5 were: -0.13 (0.78) % for antithrombin III, 1.95 (2.97) % for factor VIII,  
-2.79 (3.88) mg/dL for fibrinogen, 0.56 (0.54) IU/mL for plasminogen activator inhibitor, 
0.06 (0.19) ng/mL for tissue plasminogen activator, and -0.13 (0.15) μg/mL for D-Dimer (all 
p-values > 0.05). 
5. Discussion 
The mechanisms responsible for the consistently reported association between fine particle 
exposure and cardiovascular disease mortality and morbidity are not fully understood. 
Previous studies have suggested several possible underlying mechanisms, including cardiac 
autonomic impairment as measured by lower HRV (Creason et al. 2001; Gold et al. 2000; He 
et al. 2010; Liao et al. 1999, 2004; Pope et al. 1999) and effects on ventricular repolarization 
(Campen et al. 2006; Ghelfi et al. 2008; Henneberger et al. 2005; Liao et al. 2010; Lux and 
Pope 2009; Samet et al. 2009; Yue et al. 2007), T-wave alternans (Zanobetti et al. 2009), 
myocardium ischemia (Zhang et al. 2009), and arrhythmias (Berger et al. 2006; Dockery et al. 
2005; Eblet et al. 2005; Liao et al. 2009; Sarnat et al. 2006).  We conducted this study to 
systematically examine all of these cardiac electrophysiological parameters in one study 
population under a single standardized personal PM2.5 exposure. With both PM2.5 exposure 
and ECG based parameters assessed in parallel for 24 hours, and subsequently divided as 
30-minute based segment specific measures, we can apply distributed lag methods to 
identify the suggested time-course of associations, the lagged time of any significant 
associations between PM2.5 and ECG parameters.  
Since the associations we found on each of the five ECG-based parameter domains have 
been published (7;16-19), we selected to use 1-2 parameters from each domain to illustrate 
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the overall pattern of the time-courses of elevated PM2.5 on ECG parameters.  The following 
patterns are clearly shown in Tables 2 and 3: 
1. The effects on HRV as measures of cardiac autonomic modulation were limited to 
within approximately 5.5 hours of the PM2.5 exposure; 
2. The effects on heart rate corrected QT as measure of ventricular repolarization were 
limited to within approximately 4 hours of the PM2.5 exposure;  
3. The effects on ST-height as measures of ischemic potential were limited to within 
approximately 2.5 hours of the PM2.5 exposure;  
4. The effects on P-wave based parameters as measures of atrial fibrillation (Afib) 
vulnerability were limited to within approximately 2 hours of the PM2.5 exposure; and  
5. The effects on the frequency of ventricular ectopy were limited to within approximately 
60 minutes. 
To our knowledge, this is the first study designed to have sufficient temporal resolution of 
both exposure and ECG variables, e.g. on the 30-minute basis of exposure, outcome, and 
covariables.  Such a study design enabled us to examine the acute effect of PM2.5 exposure 
on various ECG-based parameters. Another major strength of this study is that PM2.5 
exposures, the ECG outcome data, and the covariables were measured at the individual 
level on a real-time basis over 24 hours. With these individual-level data, we can adjust for 
individual-level time-varying and non-time-varying confounding factors. Overall, our data 
provide evidence of acute effects of PM2.5 exposure on cardiac electrophysiological profiles.   
Mechanisms that would explain the associations between various ECG parameters and 
PM2.5 exposure are unknown at this time. It is biologically plausible that exposures to PM2.5 
directly reduce parasympathetic modulation and increase sympathetic modulation, 
resulting in longer ventricular repolarization, elevated ST-height, increased Afib 
vulnerability, and a decreased threshold for arrhythmia.  Since HRV is a reliable measure of 
cardiac autonomic modulation, and most published studies have suggested that PM 
exposure is associated with lower HRV indices,  we repeated all of our analyses to include 
adjustment for HRV variables in the final models.  In general, associations between PM2.5 
and various ECG-based parameters were attenuated but still remained statistically 
significant when we adjusted for HRV variables. These HRV-adjusted findings are 
consistent with an intermediate effect of PM exposure on autonomic modulation. However, 
adjustment for HRV parameters did not completely eliminate the associations between 
PM2.5 and various ECG parameters suggesting that other mechanisms might also explain the 
associations.  For the inflammatory responses to PM2.5 pathway, our relatively low levels of 
24-hour mean PM2.5 exposure are not associated with blood inflammation markers. These 
null finding suggest that more studies on the chronic exposure and inflammatory responses 
are needed to elucidate the sub-acute and chronic effects of PM on systemic inflammation as 
a mechanistic link between PM and cardiac electrophysiology and cardiopulmonary disease. 
For the blood coagulation and thrombosis potential responses to PM2.5 pathway, the 24-hour 
mean levels of PM2.5 exposure were not associated with blood hemostatic factors.  These null 
findings suggest that more studies on chronic PM exposure and hemostatic factors are 
needed to elucidate their role in the pathophysiologic effects of air pollution on deep vein 
thrombosis and cardiopulmonary disease. In a just published study by Zuurbier and co-
workers [37], it was concluded that air pollution exposure during commuting was not 
consistently associated with acute changes in inflammation markers, blood cell counts or 
blood coagulation markers in individuals.  It should be noted that individuals in this study 
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were exposed to higher levels of traffic-related pollutants than the APACR study 
participants.  
The APACR study has several limitations. First, our findings may not apply to smokers or 
persons with a recent acute cardiac event, as such persons were excluded from the study 
population. Second, the majority of participants reported that they stayed indoors most of 
the time during the 24-hour study period, except when they had to travel by automobile, 
and they had limited exposure to second hand cigarette smoke. Thus, participants had 
relatively low levels of exposure to PM2.5 and we cannot determine whether exposures at 
higher levels would exhibit similar associations. Third, it is well known that sympathetic 
nervous activity increases during physical activity, which could be related to higher PM2.5 
exposure if it occurs outdoors.  Thus, it is possible that the PM2.5 and ECG-parameters 
associations in this study were confounded by physical activity.  However, the vast majority 
of our participants reported staying indoors 97% of the 24 hour study period reduces the 
possibility that the consistent associations were mainly due to outdoor activity confounding.  
Fourth, the ECG data were not collected under a controlled, supine-position setting, and 
short-term variation due to other factors that may impact the ECG parameters cannot be 
fully accounted for in our analysis. However, it is not feasible to keep a healthy participant 
in a supine indoor position for 24 hours, and even if this were achieved, the results from 
such a study design would not be generalizable to a real-world situation.  
6. Conclusions  
The data from the APACR study enabled us to systematically examine the acute effects of 
PM2.5 exposures on various clinically relevant cardiac electrophysiological disturbances. In 
general, higher PM2.5 is adversely associated with all five major ECG parameters we 
analyzed, with the adverse effects occurring acutely (within 2-5 hours of elevated PM2.5) or 
ultra acutely (within 0.5 hr of elevated PM2.5).  These adverse effects on ECG parameters 
may trigger the onset of acute cardiac events and cumulatively over time, may result in 
increased risk of cardiac disease.  Thus, it is possible that PM2.5 exposure is associated with 
cardiovascular and cerebral vascular disease by first affecting the cardiac electrophysiology.  
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